Click on the image to see the full-sized ad and get all the info on AdPharm.

29 more Cymbalta ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

For the core symptoms of Major Depressive Disorder (MDD) & Generalized Anxiety Disorder (GAD) in adults
See the effect of Lexapro

Proven efficacy in MDD and GAD

Depressed Mood – Tension – Anxiety

[FLASH]Now FDA approved for MDD in adolescents aged 12 to 17

Escitalopram (trade names Lexapro, Cipralex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder and generalized anxiety disorder in adults; other indications include social anxiety disorder, panic disorder and obsessive-compulsive disorder. Escitalopram is the S-stereoisomer (enantiomer) of the earlier Lundbeck drug citalopram (Celexa), hence the name escitalopram. Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and, as a result has fewer side effects not related to its serotonergic activity. According to a meta-analysis of 12 new-generation antidepressants, escitalopram and sertraline (Zoloft) are the best in terms of efficacy and acceptability in the acute-phase treatment of adults with major depression; however, sertraline may be a better choice because of the lower cost.

More on Wikipedia

Brand name: Lexapro
Generic name/category: Escitalopram, Selective serotonin reuptake inhibitors (SSRI)
Company: Forest pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: two-page
Publication/Aired: Managed Healthcare Executive – August 2009

To see all of this brand’s ads on AdPharm, click here
4 views
Sep 05, 2009

Visit AdPharm.net for more pharmaceutical ads